SCHEMBL9044459

SCHEMBL9044459

c1cnc2[nH]c(NC3CCNCC3)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.48
HRH3 Q9Y5N1 1/20 0.44
PIM1 P11309 2/20 0.43
CYP1A2 P05177 3/20 0.43
HSD17B10 Q99714 2/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALOX15 P16050 1/20 0.43
HIF1A Q16665 1/20 0.43
MKNK1 Q9BUB5 1/20 0.43
CYP3A4 P08684 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
CDC7 O00311 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
BRD4 O60885 1/20 0.40
ATAD2 Q6PL18 1/20 0.40
PDE10A Q9Y233 1/20 0.39
IKBKB O14920 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9535416 0.95 PIM1 (0.48) PTPN11HRH3PIM1CYP1A2HSD17B10
Hydrochloric Acid SCHEMBL9689129 0.93 PIM1 (0.47) PTPN11HRH3PIM1CYP1A2HSD17B10
SCHEMBL9689165 0.92 MKNK1 (0.45) PTPN11MKNK1BRD4ATAD2
Hydrochloric Acid SCHEMBL9688928 0.90 MKNK1 (0.44) PTPN11MKNK1BRD4ATAD2
Bromide SCHEMBL9689909 0.90 MKNK1 (0.44) PTPN11MKNK1BRD4ATAD2
Hydrochloric Acid SCHEMBL9690717 0.90 MKNK1 (0.44) PTPN11MKNK1BRD4ATAD2
Citric Acid SCHEMBL9043866 0.83 PTPN11 (0.40) PTPN11HRH3CYP1A2HSD17B10USP2
SCHEMBL9534992 0.82 CDC7 (0.54) HRH3PIM1CDC7DBF4BRD4
Hydrochloric Acid SCHEMBL9535340 0.81 CDC7 (0.53) HRH3PIM1CDC7DBF4BRD4
SCHEMBL382481 0.79 JAK1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0464927-B1 3-[(5-Methyl-2-furanyl)methyl]-N-(4-piperidinyl)-3H-imidazo[4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate JANSSEN PHARMACEUTICA NV (BE) 1996-09-04 EP claimed
EP-0232937-B1 ANTI-HISTAMINIC COMPOSITIONS CONTAINING N-HETEROCYCLYL-4-PIPERIDINAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-19 EP claimed
EP-0464927-B1 3-[(5-Methyl-2-furanyl)methyl]-N-(4-piperidinyl)-3H-imidazo[4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate JANSSEN PHARMACEUTICA NV (BE) 1996-09-04 EP disclosed
EP-0282133-B1 1-ALKYL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-28 EP disclosed
EP-0295742-B1 NOVEL N-(4-PIPERIDINYL) BICYCLIC CONDENSED 2-IMIDAZOLAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-26 EP disclosed
EP-0232937-B1 ANTI-HISTAMINIC COMPOSITIONS CONTAINING N-HETEROCYCLYL-4-PIPERIDINAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-19 EP disclosed
EP-0282133-A2 1-alkyl substituted benzimidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-09-14 EP disclosed